Meridian Bioscience reported $20.16M in EBITDA for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Abbott ABT:US $ 3042M 769M
Atrion ATRI:US 12.8M 117K
Becton, Dickinson and BDX:US $ 1368M 274M
Bio Rad Laboratories BIO:US $ 196.9M 46.12M
Cerulean Pharma CERU:US $ -12.66M 3.51M
Cerus CERS:US $ -10.36M 3.26M
Genmark Diagnostics GNMK:US $ -0.46M 1.15M
Luminex LMNX:US $ 21.3M 3.09M
Myriad Genetics MYGN:US $ -65.7M 63.6M
Neogen NEOG:US $ 27.43M 1.24M
Oxford Immunotec Global OXFD:US $ 0.79M 10.16M
Quidel QDEL:US $ 294.63M 255.81M
Sientra SIEN:US $ -10.66M 2.22M
Staar Surgical STAA:US $ 8.76M 2.78M
Thermo Fisher Scientific TMO:US $ 2924M 24M
Trinity Biotech TRIB:US 7.09M 3.21M